Back to results
US 2020/0121784 A1Published application
Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
AssigneeQu Biologics Inc.
InventorHarold David Gunn
Life of this patent
Estimating the term…
Abstract
The invention provides in part methods of treating cancers of a specific organ or tissue by administering a composition that is antigenically specific for one or more microbes that are pathogenic in the specific organ or tissue in which the cancer is situated.
Claims12
1-97. (canceled)
A method for formulating an immunogenic composition for treating a cancer situated in a specific organ or tissue in a human patient, comprising:
- selecting at least one bacterial pathogen that is pathogenic in the specific organ or tissue of the patient within which the cancer is situated;
- producing an antigenic composition comprising antigenic determinants that together are specific for the bacterial pathogen;
- and,
- formulating the antigenic composition for administration as an immunogenic composition capable of eliciting an immune reaction to treat the cancer in the patient, wherein the antigenic composition is formulated for subcutaneous injection or intradermal injection.
1 more element
Dependencies are inferred from the claim text.